Features INHSU 2022: Canada’s key takeaways on hepatitis C elimination and the health of people who us drugs CATIE — Canada’s Source for HIV and Hepatitis C Information — attended the INHSU 2022 conference and has created a… 9 January 2023
News Introducing INHSU’s new board members Following the General Annual Meeting, we are pleased to welcome our four new board members: Peter Vickerman, Ernesto Cortes, Mercy… 19 December 2022
Features Safe supply as a healthcare intervention for people who use drugs- key takeaways from INHSU 2022 One of the emerging themes from the 10th International Conference on Health and Hepatitis in Substance Users – INHSU 2022… 1 December 2022
Features Harm reduction intervention case studies – key takeaways from INHSU 2022 Harm reduction interventions were a core focus at the 10th International Conference on Health and Hepatitis in Substance Users –… 1 December 2022
Features Hepatitis C in the custodial settings- key takeaways from INHSU 2022 Throughout the 10th International Conference on Health and Hepatitis in Substance Users – INHSU 2022 – we welcomed experts to… 1 December 2022
Features Hepatitis C and people who use drugs – key takeaways from INHSU 2022 From the impact of DAA treatment on quality of life to the question ‘are women being left behind?’, INHSU 2022… 1 December 2022
Features INHSU 2022 Community Statement Each year, ahead of the main conference, INHSU’s Community Committee hosts a pre-conference event, welcoming the global community of people… 1 December 2022
Features Tips and tricks for getting your research published During the INHSU 2022 conference in Glasgow, INHSU EMCR (our early-mid-career researcher special interest group) hosted a session called ‘Tips… 30 November 2022
Features Key takeaways from the ASCEND Symposium On September 19th, the INHSU team headed to the ASCEND Symposium (Advancing the health of people who use drugs: hepatitis… 28 September 2022